Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1).
about
Critical role of hnRNP A1 in HTLV-1 replication in human transformed T lymphocytesThe use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene deliveryHTLV-1 Rex Tunes the Cellular Environment Favorable for Viral ReplicationInteraction of retroviral Tax oncoproteins with tristetraprolin and regulation of tumor necrosis factor-alpha expressionA human T-cell lymphotropic virus type 1 enhancer of Myc transforming potential stabilizes Myc-TIP60 transcriptional interactionsUndifferentiated Pleomorphic Sarcoma and the Importance of Considering the Oncogenic and Immune-Suppressant Role of the Human T-Cell Lymphotropic Virus Type 1: A Case Report.Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteins.Co-dependence of HTLV-1 p12 and p8 functions in virus persistenceAcetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)/c-MYC.Association of SRC-related kinase Lyn with the interleukin-2 receptor and its role in maintaining constitutive phosphorylation of JAK/STAT in human T-cell leukemia virus type 1-transformed T cells.Cellular transformation by the HTLV-I Tax protein, a jack-of-all-trades.Epidemiological aspects of retrovirus (HTLV) infection among Indian populations in the Amazon Region of Brazil.Orf-I and orf-II-encoded proteins in HTLV-1 infection and persistence.Prevalence of Human T-Lymphotropic Virus Types I and II in Patients With Hematological Disorders in Isfahan, Iran.In vivo and in vitro treatment of HTLV-1 and HTLV-2 infected cells with arsenic trioxide and interferon-alpha.Early and transient reverse transcription during primary deltaretroviral infection of sheep.Receptor-directed therapy of T-cell leukemias and lymphomas.Constitutive release of IFNγ and IL2 from peripheral blood mononuclear cells of rhesus macaques (Macaca mulatta) infected with simian T-lymphotropic virus type 1.C-terminal residues of mature human T-lymphotropic virus type 1 protease are critical for dimerization and catalytic activity.HTLV gene regulation: because size matters, transcription is not enough.Adult T-cell leukemia/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapyHematopoietic SCT for adult T-cell leukemia/lymphoma: a review.HTLV-1 Rex: the courier of viral messages making use of the host vehicle.Comparative studies on retroviral proteases: substrate specificity.Analyses of HTLV-1 sequences suggest interaction between ORF-I mutations and HAM/TSP outcome.The HTLV-I p30 interferes with TLR4 signaling and modulates the release of pro- and anti-inflammatory cytokines from human macrophages.In vitro peptide immunization of target tax protein human T-cell leukemia virus type 1-specific CD4+ helper T lymphocytes.Inhibition of apoptosis by human T-lymphotropic virus type-1 tax protein.Mitochondrial alterations induced by the p13II protein of human T-cell leukemia virus type 1. Critical role of arginine residues.Estradiol represses human T-cell leukemia virus type 1 Tax activation of tumor necrosis factor-alpha gene transcription.[Cloning and expression of the transmembranic glycoprotein from human T cell lymphotropic virus in a prokaryotic system].Identification of clonally rearranged T-cell receptor beta chain genes in HTLV-I carriers as a potential instrument for early detection of neoplasia.Narrow substrate specificity and sensitivity toward ligand-binding site mutations of human T-cell Leukemia virus type 1 protease.Human T-cell leukemia virus type 1 Tax interacts with Chk1 and attenuates DNA-damage induced G2 arrest mediated by Chk1.Utilization of the CBP but not the p300 co-activator by human T-lymphotropic virus type-2 Tax for p53 inhibition.The human T-cell leukemia virus type-1 p30II protein activates p53 and induces the TIGAR and suppresses oncogene-induced oxidative stress during viral carcinogenesis.The TP53-Induced Glycolysis and Apoptosis Regulator mediates cooperation between HTLV-1 p30II and the retroviral oncoproteins Tax and HBZ and is highly expressed in an in vivo xenograft model of HTLV-1-induced lymphoma.
P2860
Q24796854-4482E76A-F646-4807-99FB-5492309B7593Q24804110-C8FCF198-5C45-49AA-BA67-A93CE6B6D582Q28066382-2A21B354-A14B-460B-BD2A-13F8DF81E2DFQ28117697-C535FFB4-E171-4749-9A50-DF7D259091BBQ28259102-E35B5AA7-1EFA-4655-B81F-70F6FA16ABA9Q33720524-63557366-54AB-4308-A8C6-6F3F0CDC7363Q34258809-D21D3A6E-A709-49F2-8E33-88C892D9A348Q34466396-B3FDB9C5-669A-415A-812A-D5E5B00A6700Q35071356-C8EE64B2-C9F6-4D5E-B22C-32EF4B546BAEQ35076820-DF927B03-4DC4-4250-A16F-C9950150E689Q35196610-5F143E25-EB34-4144-ABDF-369A126AAD48Q35218637-65D55F6F-8598-44D4-8ABD-2BA145F0E3A5Q35261449-B66435F0-6515-431D-AD9A-919CBEDE7AEDQ35964941-02E7F1C3-0F11-4337-BC98-3516BC974187Q35994968-223F99D5-D08B-458C-AA08-85388E1BB5D8Q36502550-415C5DAD-833D-46AD-8FAE-4EA91EA99749Q37196716-450A44CA-F5A8-4699-A5C7-2754D5893A9CQ37401051-A443526F-7E1D-4802-BA3F-DB1A4EFB5394Q37424824-7162DE4E-2876-4600-8402-026A604DFCEBQ37470581-F064360B-7218-453C-BBEB-BCAF1A0CBDEFQ37588395-898F365C-D31B-46C6-8E76-33339A844C44Q37848038-7286F5DA-E6D7-4CD9-8AB9-F7F82C4826E9Q38042924-805CC69A-E923-4423-83C9-FF89DA68D678Q38613993-7AFCE91F-EC35-4D4E-AB56-B0AA0DE48BFCQ38894410-45B5883D-9DC0-4D15-9A32-E776463F34FDQ40265627-964178C6-25B2-4FAA-8EE8-8FD6FCB7DB2CQ40267146-2EE80938-547C-4994-AE79-719489077E4AQ40576047-F4D28BED-69B0-43DD-B167-2FDA38E8B452Q44047564-9CF87730-3582-4191-AB01-DC8EA08D1846Q44141078-FA985924-00E3-47A0-A98F-55F42E544E86Q44532039-2AC56F9E-DFC8-4C89-98BA-3992FB098D98Q44728860-71601205-C1FB-4C18-89EB-F942B93D4CE2Q44854785-6B53FABE-5149-438C-B6C8-0DCFE083AE1FQ44859691-E61CE757-8987-4D71-99B5-0BFC9A457A38Q45637777-60169CEC-18C3-45FF-9691-DCCBF185CE6DQ49806891-CA466B63-F71A-483C-B151-D18130FEFF8EQ54205980-4F45C166-36A0-43DB-B167-010653B037CB
P2860
Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1).
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Molecular biology and pathogen ...... otropic virus Type-1 (HTLV-1).
@ast
Molecular biology and pathogen ...... otropic virus Type-1 (HTLV-1).
@en
type
label
Molecular biology and pathogen ...... otropic virus Type-1 (HTLV-1).
@ast
Molecular biology and pathogen ...... otropic virus Type-1 (HTLV-1).
@en
prefLabel
Molecular biology and pathogen ...... otropic virus Type-1 (HTLV-1).
@ast
Molecular biology and pathogen ...... otropic virus Type-1 (HTLV-1).
@en
P2093
P2860
P921
P1476
Molecular biology and pathogen ...... otropic virus Type-1 (HTLV-1).
@en
P2093
G Franchini
J M Johnson
P2860
P304
P356
10.1046/J.1365-2613.2001.00191.X
P577
2001-06-01T00:00:00Z